Aligos Therapeutics, Inc. (ALGS) Ownership

$10.07

south_east
-$0.17 (-1.66%)
Day's range
$9.6
Day's range
$10.18

Aligos Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
WOODLINE PARTNERS LP 11/14/2025 468.20 K $4.59 M   -9.67% 4.52%
DEEP TRACK CAPITAL, LP 11/14/2025 444.11 K $4.35 M   0.00% 4.29%
ALYESKA INVESTMENT GROUP, L.P. 11/17/2025 412.00 K $4.04 M   0.00% 3.98%
SIO CAPITAL MANAGEMENT, LLC 11/13/2025 335.94 K $3.29 M   0.00% 3.25%
READYSTATE ASSET MANAGEMENT LP 11/07/2025 203.11 K $1.99 M   48.49% 1.96%
VANGUARD GROUP INC 11/07/2025 171.69 K $1.68 M   22.83% 1.66%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2025 140.00 K $1.37 M   0.00% 1.35%
BAKER BROS. ADVISORS LP 11/14/2025 83.06 K $813.94 K   0.00% 0.80%
HHLR ADVISORS, LTD. 11/14/2025 76.25 K $747.22 K   0.00% 0.74%
LPL FINANCIAL LLC 11/12/2025 55.12 K $540.18 K   83.12% 0.53%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 55.02 K $539.19 K   4.71% 0.53%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 47.08 K $461.59 K   38.28% 0.45%
TWO SIGMA INVESTMENTS, LP 11/14/2025 39.00 K $382.15 K   222.99% 0.38%
SQUAREPOINT OPS LLC 11/14/2025 30.49 K $298.83 K   64.04% 0.29%
UBS GROUP AG 11/13/2025 16.18 K $158.58 K   489.94% 0.16%
BLACKROCK, INC. 11/12/2025 13.04 K $127.79 K   0.00% 0.13%
MORGAN STANLEY 11/14/2025 11.28 K $110.58 K   181.75% 0.11%
CITADEL ADVISORS LLC 11/14/2025 10.31 K $101.04 K   -32.16% 0.10%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 10.11 K $99.05 K   100.00% 0.10%
NORTHCREST ASSET MANANGEMENT, LLC 10/29/2025 10.00 K $98.40 K   100.00% 0.10%
QUEST PARTNERS LLC 11/03/2025 6.77 K $66.37 K   13.95% 0.07%
WELLS FARGO & COMPANY/MN 11/13/2025 3.17 K $31.07 K   -76.98% 0.03%
GOLDEN STATE WEALTH MANAGEMENT, LLC 11/03/2025 2.67 K $26.21 K   0.00% 0.03%
ROYAL BANK OF CANADA 11/14/2025 2.13 K $21.00 K   0.00% 0.02%
BANK OF AMERICA CORP /DE/ 11/14/2025 1.91 K $18.76 K   -26.72% 0.02%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 11/14/2025 1.00 K $9.80 K   100.00% 0.01%
GLOBAL RETIREMENT PARTNERS, LLC 10/21/2025 800 $7.84 K   100.00% 0.01%
JPMORGAN CHASE & CO 11/26/2025 708 $6.94 K   2,623.08% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 11/14/2025 457 $4.48 K   -58.57% 0.00%
SBI SECURITIES CO., LTD. 11/05/2025 26 $255   0.00% 0.00%
BARCLAYS PLC 11/12/2025 15 $147   100.00% 0.00%
ZRC WEALTH MANAGEMENT, LLC 10/14/2025 4 $40   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 3 $29   -99.83% 0.00%
FMR LLC 11/13/2025 0 $0   -100.00% 0.00%
RAYMOND JAMES FINANCIAL INC 11/14/2025 0 $0   -100.00% 0.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 0 $0   -100.00% 0.00%
GOLDMAN SACHS GROUP INC 11/14/2025 0 $0   -100.00% 0.00%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 0 $0   -100.00% 0.00%
TANG CAPITAL MANAGEMENT LLC 11/14/2025 0 $0   -100.00% 0.00%
MILLENNIUM MANAGEMENT LLC 11/14/2025 0 $0   -100.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 0 $0   -100.00% 0.00%
XTX TOPCO LTD 11/14/2025 0 $0   -100.00% 0.00%

Aligos Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 47 institutional investors and hedge funds held shares of Aligos Therapeutics, Inc.. The most heavily invested institutionals were:

Woodline Partners LP: 468,199

Deep Track Capital, LP: 444,110

Alyeska Investment Group, L.P.: 412,000

Sio Capital Management, LLC: 335,937

READYSTATE ASSET MANAGEMENT LP: 203,113

VANGUARD GROUP INC: 171,689

25.62% of Aligos Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 5.92 M shares in the last 24 months. This purchase volume represents approximately $59.63 M in transactions.